ZNF337
gene geneOn this page
Also known as dJ694B14.1
Summary
ZNF337 (zinc finger protein 337, HGNC:15809) is a protein-coding gene on chromosome 20p11.21, encoding Zinc finger protein 337 (Q9Y3M9). May be involved in transcriptional regulation.
This gene encodes a zinc finger domain containing protein. The function of this protein has yet to be determined. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 26152 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 130 total
- MANE Select transcript:
NM_015655
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15809 |
| Approved symbol | ZNF337 |
| Name | zinc finger protein 337 |
| Location | 20p11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ694B14.1 |
| Ensembl gene | ENSG00000130684 |
| Ensembl biotype | protein_coding |
| Entrez | 26152 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 15 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000252979, ENST00000376436, ENST00000481610, ENST00000878466, ENST00000878467, ENST00000878468, ENST00000878469, ENST00000878470, ENST00000878471, ENST00000878472, ENST00000878473, ENST00000912968, ENST00000912969, ENST00000954845, ENST00000954846, ENST00000954847
RefSeq mRNA: 2 — MANE Select: NM_015655
NM_001290261, NM_015655
CCDS: CCDS13174
Canonical transcript exons
ENST00000252979 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001796964 | 25685996 | 25686122 |
| ENSE00001886932 | 25696759 | 25696853 |
| ENSE00003483333 | 25686391 | 25686466 |
| ENSE00003530440 | 25685567 | 25685662 |
| ENSE00003849082 | 25673195 | 25677037 |
Expression profiles
Bgee: expression breadth ubiquitous, 286 present calls, max score 95.42.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.8143 / max 104.1237, expressed in 1721 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 186811 | 5.9856 | 1639 |
| 186810 | 1.6286 | 1002 |
| 186809 | 1.2001 | 785 |
Top tissues by expression
296 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar hemisphere | UBERON:0002245 | 95.42 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.36 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.35 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 94.47 | gold quality |
| cerebellum | UBERON:0002037 | 94.46 | gold quality |
| cortical plate | UBERON:0005343 | 93.28 | gold quality |
| right uterine tube | UBERON:0001302 | 92.66 | gold quality |
| ganglionic eminence | UBERON:0004023 | 91.18 | gold quality |
| cerebellar vermis | UBERON:0004720 | 91.03 | gold quality |
| left ovary | UBERON:0002119 | 89.74 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 89.39 | gold quality |
| lower esophagus | UBERON:0013473 | 89.36 | gold quality |
| diaphragm | UBERON:0001103 | 89.33 | gold quality |
| right ovary | UBERON:0002118 | 88.95 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 88.80 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 88.75 | gold quality |
| granulocyte | CL:0000094 | 88.66 | gold quality |
| ventricular zone | UBERON:0003053 | 88.57 | gold quality |
| thymus | UBERON:0002370 | 88.53 | gold quality |
| superficial temporal artery | UBERON:0001614 | 88.52 | gold quality |
| body of uterus | UBERON:0009853 | 88.36 | gold quality |
| endocervix | UBERON:0000458 | 88.15 | gold quality |
| embryo | UBERON:0000922 | 87.88 | gold quality |
| adenohypophysis | UBERON:0002196 | 87.70 | gold quality |
| ovary | UBERON:0000992 | 87.65 | gold quality |
| left uterine tube | UBERON:0001303 | 87.64 | gold quality |
| endothelial cell | CL:0000115 | 87.54 | gold quality |
| pituitary gland | UBERON:0000007 | 87.52 | gold quality |
| olfactory bulb | UBERON:0002264 | 87.43 | silver quality |
| right frontal lobe | UBERON:0002810 | 87.42 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | no | 660.89 |
| E-ANND-3 | no | 1.51 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
73 targeting ZNF337, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-8076 | 99.78 | 68.52 | 1170 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-519A-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519B-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519C-3P | 99.67 | 71.67 | 1870 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-4502 | 99.65 | 66.99 | 1021 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp78 | ENSMUSG00000055150 |
| rattus_norvegicus | ENSRNOG00000083797 | |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 337 — Q9Y3M9 (reviewed: Q9Y3M9)
All UniProt accessions (1): Q9Y3M9
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y3M9-1 | 1 | yes |
| Q9Y3M9-2 | 2 |
RefSeq proteins (2): NP_001277190, NP_056470* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096, PF01352
UniProt features (30 total): zinc finger region 20, sequence variant 2, sequence conflict 2, chain 1, domain 1, region of interest 1, compositionally biased region 1, cross-link 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y3M9-F1 | 75.18 | 0.07 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 458
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 79 (showing top):
MORF_SNRP70, PUJANA_CHEK2_PCC_NETWORK, MODULE_205, BLALOCK_ALZHEIMERS_DISEASE_UP, MORF_PDPK1, MORF_ORC1L, MORF_MYST2, chr20p11, MORF_CNTN1, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP, IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP, CSR_EARLY_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CHAF1B_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
722 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF337 | PCMTD2 | Q9NV79 | 470 |
| ZNF337 | DRC5 | Q5JU00 | 466 |
| ZNF337 | ANKRA2 | Q9H9E1 | 391 |
| ZNF337 | PRR32 | B1ATL7 | 378 |
| ZNF337 | DEFB115 | Q30KQ5 | 370 |
| ZNF337 | TLCD2 | A6NGC4 | 350 |
| ZNF337 | CCDC125 | Q86Z20 | 350 |
| ZNF337 | ZNF518A | Q6AHZ1 | 348 |
| ZNF337 | GATD1 | Q8NB37 | 348 |
| ZNF337 | PARP8 | Q8N3A8 | 345 |
| ZNF337 | ANKRD30B | Q9BXX2 | 327 |
| ZNF337 | TASOR2 | Q5VWN6 | 324 |
| ZNF337 | TXNDC15 | Q96J42 | 323 |
| ZNF337 | RAB6B | Q9NRW1 | 310 |
| ZNF337 | PACRG | Q96M98 | 306 |
IntAct
31 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF337 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CALCOCO2 | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HMBOX1 | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RPGRIP1 | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF337 | CALCOCO2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF337 | RPGRIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF337 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC125 | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GNMT | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF337 | PTGER4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CCDC85B | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF337 | IPO8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF460 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| MRFAP1L1 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF337 | CCDC125 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GNMT | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.000 |
| COMMD3 | ZNF337 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (19): ZNF337 (Two-hybrid), ZNF337 (Two-hybrid), RPGRIP1 (Two-hybrid), HMBOX1 (Two-hybrid), KRT40 (Two-hybrid), KRTAP10-7 (Two-hybrid), ZNF337 (Two-hybrid), ZNF337 (Two-hybrid), ZNF337 (Two-hybrid), CCDC125 (Two-hybrid), ZNF337 (Two-hybrid), ZNF337 (Affinity Capture-MS), ZNF337 (Affinity Capture-MS), ZNF337 (Affinity Capture-MS), ZNF337 (Affinity Capture-MS)
ESM2 similar proteins: A6QLU5, O75820, P08043, P10076, P10755, P16374, P16415, P17014, P17021, P17027, P17039, P51786, Q08AN1, Q14588, Q3KP31, Q3ZCX4, Q52M93, Q5MCW4, Q5R5Q6, Q5R5S6, Q5R5Y7, Q5RB30, Q5REA0, Q5REI6, Q6P3V2, Q6P9Y7, Q6ZNA1, Q7TSH9, Q7TSI0, Q7Z3V5, Q80W31, Q86UE3, Q86YE8, Q8BPP0, Q8N141, Q8N4W9, Q8N9F8, Q8NDQ6, Q8TBZ5, Q96ND8
Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
130 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 125 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
534 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:25685990:GCTTA:G | donor_loss | 1.0000 |
| 20:25685991:CTTA:C | donor_loss | 1.0000 |
| 20:25685992:TTA:T | donor_loss | 1.0000 |
| 20:25685993:TACCT:T | donor_loss | 1.0000 |
| 20:25685995:C:CA | donor_loss | 1.0000 |
| 20:25685994:A:AC | donor_gain | 0.9900 |
| 20:25685995:C:CC | donor_gain | 0.9900 |
| 20:25686119:AAGCC:A | acceptor_loss | 0.9900 |
| 20:25686123:C:CA | acceptor_loss | 0.9900 |
| 20:25686124:TGTAA:T | acceptor_loss | 0.9900 |
| 20:25686693:CATCA:C | donor_gain | 0.9900 |
| 20:25677033:TATTC:T | acceptor_gain | 0.9800 |
| 20:25686125:G:C | acceptor_loss | 0.9800 |
| 20:25686385:TCTCA:T | donor_loss | 0.9800 |
| 20:25686386:CTCAC:C | donor_loss | 0.9800 |
| 20:25686387:TCACC:T | donor_loss | 0.9800 |
| 20:25686388:CACC:C | donor_loss | 0.9800 |
| 20:25686389:AC:A | donor_loss | 0.9800 |
| 20:25686390:C:CT | donor_loss | 0.9800 |
| 20:25677964:T:A | donor_gain | 0.9700 |
| 20:25686123:C:CC | acceptor_gain | 0.9700 |
| 20:25686390:CCTGT:C | donor_gain | 0.9700 |
| 20:25685995:CCTA:C | donor_gain | 0.9600 |
| 20:25686035:C:A | donor_gain | 0.9600 |
| 20:25686692:A:AC | donor_gain | 0.9600 |
| 20:25686693:C:CC | donor_gain | 0.9600 |
| 20:25685734:C:T | acceptor_gain | 0.9500 |
| 20:25686121:GC:G | acceptor_gain | 0.9500 |
| 20:25686122:CC:C | acceptor_gain | 0.9500 |
| 20:25677037:CCT:C | acceptor_loss | 0.9400 |
AlphaMissense
4951 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:25676049:A:C | F413L | 0.998 |
| 20:25676049:A:T | F413L | 0.998 |
| 20:25676051:A:G | F413L | 0.998 |
| 20:25675293:G:C | F665L | 0.997 |
| 20:25675293:G:T | F665L | 0.997 |
| 20:25675295:A:G | F665L | 0.997 |
| 20:25675377:G:C | F637L | 0.997 |
| 20:25675377:G:T | F637L | 0.997 |
| 20:25675379:A:G | F637L | 0.997 |
| 20:25675461:A:C | F609L | 0.997 |
| 20:25675461:A:T | F609L | 0.997 |
| 20:25675463:A:G | F609L | 0.997 |
| 20:25675545:G:C | F581L | 0.997 |
| 20:25675545:G:T | F581L | 0.997 |
| 20:25675547:A:G | F581L | 0.997 |
| 20:25675881:A:C | F469L | 0.997 |
| 20:25675881:A:T | F469L | 0.997 |
| 20:25675883:A:G | F469L | 0.997 |
| 20:25675965:A:C | F441L | 0.997 |
| 20:25675965:A:T | F441L | 0.997 |
| 20:25675967:A:G | F441L | 0.997 |
| 20:25676108:G:C | H394D | 0.997 |
| 20:25676133:A:C | F385L | 0.997 |
| 20:25676133:A:T | F385L | 0.997 |
| 20:25676135:A:G | F385L | 0.997 |
| 20:25676385:A:C | F301L | 0.997 |
| 20:25676385:A:T | F301L | 0.997 |
| 20:25676387:A:G | F301L | 0.997 |
| 20:25675713:A:C | F525L | 0.996 |
| 20:25675713:A:T | F525L | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000259050 (20:25688111 T>C), RS1000464402 (20:25689201 G>T), RS1000505133 (20:25683234 T>G), RS1000506668 (20:25689360 C>A), RS1000563850 (20:25683635 T>G), RS1000599568 (20:25689381 C>T), RS1000679481 (20:25695575 G>A,T), RS1000903655 (20:25676192 G>A), RS1000946526 (20:25696217 C>T), RS1001167666 (20:25677409 A>G), RS1001188028 (20:25689191 C>G), RS1001302120 (20:25677648 C>G,T), RS1001389721 (20:25678212 GAAAA>G,GAAA,GAAAAA), RS1001486801 (20:25684823 C>T), RS1001516553 (20:25684496 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006481_37 | Lung function (FEV1) | 2.000000e-07 |
| GCST006481_6 | Lung function (FEV1) | 3.000000e-10 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004314 | forced expiratory volume |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | affects expression, decreases expression, increases expression | 3 |
| Aflatoxin B1 | increases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluorohexanesulfonic acid | decreases expression | 1 |
| PCI 5002 | increases expression, affects cotreatment | 1 |
| Decitabine | affects expression | 1 |
| Acetaminophen | increases expression | 1 |
| Adenine | decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Colchicine | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Quercetin | increases expression | 1 |
| Selenium | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Triiodothyronine | increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Vitamin E | decreases expression | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.